Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q2 2019 · 10-Q
Revenue$0.00$0.00— vs Q2 2018 Net Income-$2.54M-$2.54MN/M vs Q2 2018 EPS Diluted-$0.01-$0.01N/M vs Q2 2018 Operating Income-$2,037,245N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
derived
ended Jun 30, 2019 · filed Aug 7, 2019 · 38 d after period end